RecruitingPhase 3NCT04430790

Doxapram Therapy in Preterm Infants (DOXA Trial)

Studying Apnea of prematurity

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Erasmus Medical Center
Principal Investigator
Anne Smits, MD, PhD
Universitair Ziekenhuis Leuven
Intervention
Doxapram(drug)
Enrollment
396 enrolled
Eligibility
All sexes
Timeline
20202034

Study locations (24)

Collaborators

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Nederlands Neonataal Netwerk (N3), the Netherlands · Universitaire Ziekenhuizen KU Leuven · Maternal, Infant, Child and Youth Research Network (MICYRN)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04430790 on ClinicalTrials.gov

Other trials for Apnea of prematurity

Additional recruiting or active studies for the same condition.

See all trials for Apnea of prematurity

← Back to all trials